Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

The Janus Face of Cathelicidin in Tumorigenesis

Author(s): W.K.K. Wu, J.J.Y. Sung, A.S.L. Cheng, F.K.L. Chan, S.S.M. Ng, K.F. To, X.J. Wang, L. Zhang, S.H. Wong, J. Yu and C.H. Cho

Volume 21 , Issue 21 , 2014

Page: [2392 - 2400] Pages: 9

DOI: 10.2174/0929867321666140205135351

Price: $65

Abstract

Cathelicidin is a host defense peptide with multiple innate immunity-related functions. Recent findings indicate that cathelicidin is frequently dysregulated in human cancers where it plays a paradoxical yet dominant role in the regulation of tumor malignancy. In this review, the regulation of malignant phenotypes by cathelicidin in relation to the activation of its receptors and intracellular signaling is discussed.

Keywords: Angiogenesis, apoptosis, LL-37, receptor, signaling.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy